Bob Proulx sat down with Rozalina Sarkezians, Managing Director & Founder of Health Industry Hub, for a chat about Imagion Biosystem’s work developing our breakthrough imaging agent technology to detect cancer safely and effectively.

Our CEO and Executive Chairman talked about the progress of Imagion’s first-in-human study of the MagSense technology for HER2 Breast Cancer, discussing the challenges the industry is facing to regain momentum as we live through COVID and strive to continue to create innovative solutions for patients.

You can see the complete interview by clicking below: